Knockdown of HDAC6 alleviates ventricular remodeling in experimental dilated cardiomyopathy via inhibition of NLRP3 inflammasome activation and promotion of cardiomyocyte autophagy
- PMID: 35764897
- DOI: 10.1007/s10565-022-09727-z
Knockdown of HDAC6 alleviates ventricular remodeling in experimental dilated cardiomyopathy via inhibition of NLRP3 inflammasome activation and promotion of cardiomyocyte autophagy
Abstract
Histone deacetylases (HDACs) has been implicated in cardiac diseases, while the role of HDAC6 in dilated cardiomyopathy (DCM) remains obscure. The in silico analyses predicted potential association of HDAC6 with autophagy-related genes and DCM. Thus, we evaluated the functional relevance of HDAC6 in DCM in vivo and in vitro. We developed a rat model in vivo and a cell model in vitro by doxorubicin (DOX) induction to simulate DCM. HDAC6 expression was determined in myocardial tissues of DCM rats. DCM rats exhibited elevated HDAC6 mRNA and protein expression as compared to sham-operated rats. We knocked HDAC6 down and/or overexpressed NLRP3 in vivo and in vitro to characterize their roles in cardiomyocyte autophagy. It was established that shRNA-mediated HDAC6 silencing augmented cardiomyocyte autophagy and suppressed NLRP3 inflammasome activation, thus ameliorating cardiac injury in myocardial tissues of DCM rats. Besides, in DOX-injured cardiomyocytes, HDAC6 silencing also diminished NLRP3 inflammasome activation and cell apoptosis but enhanced cell autophagy, whereas ectopic NLRP3 expression negated the effects of HDAC6 silencing. Since HDAC6 knockdown correlates with enhanced cardiomyocyte autophagy and suppressed NLRP3 inflammasome activation through an interplay with NLRP3, it is expected to be a potential biomarker and therapeutic target for DCM. 1. HDAC6 was up-regulated in DCM rats. 2. HDAC6 knockdown promoted cardiomyocyte autophagy to relieve cardiac dysfunction. 3. HDAC6 knockdown inhibited NLRP3 inflammasome and promoted cardiomyocyte autophagy. 4. Silencing HDAC6 promoted autophagy and repressed apoptosis in cardiomyocytes. 5. This study provides novel therapeutic targets for DCM.
Keywords: Autophagy; Cardiomyocytes; Dilated cardiomyopathy; Histone deacetylase 6; Inflammasome; Myocardial injury; NLRP3; Ventricular remodeling.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy.Redox Biol. 2020 Jul;34:101523. doi: 10.1016/j.redox.2020.101523. Epub 2020 Mar 30. Redox Biol. 2020. PMID: 32273259 Free PMC article.
-
Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.Life Sci. 2020 Sep 1;256:117980. doi: 10.1016/j.lfs.2020.117980. Epub 2020 Jun 16. Life Sci. 2020. PMID: 32561396
-
NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.PLoS One. 2014 Aug 19;9(8):e104771. doi: 10.1371/journal.pone.0104771. eCollection 2014. PLoS One. 2014. PMID: 25136835 Free PMC article.
-
The Role of HDAC6 in Autophagy and NLRP3 Inflammasome.Front Immunol. 2021 Oct 27;12:763831. doi: 10.3389/fimmu.2021.763831. eCollection 2021. Front Immunol. 2021. PMID: 34777380 Free PMC article. Review.
-
Mitochondria and NLRP3 inflammasome in cardiac hypertrophy.Mol Cell Biochem. 2024 Jul;479(7):1571-1582. doi: 10.1007/s11010-023-04812-1. Epub 2023 Aug 17. Mol Cell Biochem. 2024. PMID: 37589860 Review.
Cited by
-
Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.Cardiovasc Res. 2024 Oct 14;120(12):1456-1471. doi: 10.1093/cvr/cvae144. Cardiovasc Res. 2024. PMID: 39001869 Free PMC article.
-
The Role of Histone Deacetylases in NLRP3 Inflammasomesmediated Epilepsy.Curr Mol Med. 2024;24(8):980-1003. doi: 10.2174/1566524023666230731095431. Curr Mol Med. 2024. PMID: 37519210 Review.
-
Targeting histone deacetylase in cardiac diseases.Front Physiol. 2024 Jun 24;15:1405569. doi: 10.3389/fphys.2024.1405569. eCollection 2024. Front Physiol. 2024. PMID: 38983721 Free PMC article. Review.
References
-
- Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 inflammasome and autophagy. Front Immunol. 2020;11:591803. https://doi.org/10.3389/fimmu.2020.591803
-
- Caragnano A, Aleksova A, Bulfoni M, Cervellin C, Rolle IG, Veneziano C, et al. Autophagy and inflammasome activation in dilated cardiomyopathy. J Clin Med. 2019;8(10):1519. https://doi.org/10.3390/jcm8101519
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases